TENX — Tenax Therapeutics, Inc.
Quiet🖨 Heavy Printer🌀 Serial Splitter1-for-1,307 cumulative
XBRL EDGAR
from EDGAR
Case Notes
Tenax Therapeutics, Inc. has 2 reverse splits on record — cumulative 1-for-1,307. Its share count grew 802.1% over the last twelve months per XBRL EDGAR data.
Most recent stress filing: 10-Q on 2026-05-13, flagging Capital need. No S-1 or 424B supply registrations appear in the last 12 months.
The current filing record is quiet: nothing newly registered, no recent stress flags. In our dataset, quiet is where every cycle began — the absence of filings is itself a data point, not a clearance. This record will be updated as new filings land on EDGAR.
Share Count Over Time
XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 2 reverse splits on record.
Reverse Split Log
Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.
Cumulative effective ratio: 1-for-1,307— a share held at inception is now worth 1/1,307 of its original fraction.
Filing Stress Record
Stress-language flags extracted from SEC EDGAR 10-K/10-Q filings. Score 1–10 reflects language intensity.
| Date | Form | Score | Flags |
|---|---|---|---|
| 2024-08-14 | 10-Q | 3/10 | Going concernCapital needSplit intent |
| 2024-11-14 | 10-Q | 3/10 | Going concernCapital needSplit intent |
| 2025-03-26 | 10-K | 1/10 | Capital need |
| 2025-05-15 | 10-Q | 1/10 | Capital need |
| 2025-08-14 | 10-Q | 1/10 | Capital need |
| 2025-11-13 | 10-Q | 1/10 | Capital need |
| 2026-03-10 | 10-K | 1/10 | Capital need |
| 2026-05-13 | 10-Q | 1/10 | Capital need |
Source: public EDGAR records.
424B Supply Pulse
Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.